Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis.
Pain Research Forum: application of scientific social media frameworks in neuroscience.
Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4(+) T Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function.
Overview of treatment options in multiple sclerosis.
The benefits of exercise training in multiple sclerosis.
Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: The particular context of virus infection.
Anti-integrin therapy for multiple sclerosis.
The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
The role of mitochondria in axonal degeneration and tissue repair in MS.
Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities.
Fampridine – Benefit assessment according to § 35a Social Code Book V
Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies.
Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis.
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS?
RNF and Betaseron® Tolerability Study (REFORMS)
Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis.
From injection therapies to natalizumab: views on the treatment of multiple sclerosis.
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.
Is multiple sclerosis a proresolution deficiency disorder?
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.
Over six cups of coffee a day may reduce the risk of developing multiple sclerosis.
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.

Pages